Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Partnership and consent in MS treatment choice.
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Myelin Sheath Development in the Maxillary Nerve of the Newborn Pig.
A Multimodal Intervention for Patients with Secondary Progressive Multiple Sclerosis: Feasibility and Effect on Fatigue.
Systematic Review of the Economics of Multiple Sclerosis in Latin America.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Firategrast: natalizumab in a pill?
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
A Study of Efficacy and Safety of Ocrelizumab in Patients with Relapse-Remitting Multiple Sclerosis
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Delayed visual evoked response in optic neuritis.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
CellCept (Product Insert)
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.